… designed to assess the effectiveness and safety of COVID-19 convalescent plasma in
hospitalized patients. The trial used plasma collected from four blood suppliers with a range of anti-…

… hospitalized patients with COVID-19, several signals consistent with effectiveness for
convalescent plasma … Earlier use of convalescent plasma was associated with lower observed …

… Administration of convalescent plasma (CP) may be effective therapy for COVID-19. Early …
We report the early clinical experience of 20 hospitalized patients treated with CP compared …

… Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 …
and efficacy of convalescent plasma therapy in patients admitted to hospital with COVID-19. …

… convalescent plasma to risk groups with recent symptom onset will be key to identify patients
that may benefit from convalescent plasma. … Our data also show that in hospitalized patients …

… into the therapeutic use of convalescent plasma and removes biases from … convalescent
plasma was associated with a clinically meaningful mortality benefit among hospitalized patients …

… is associated with improved clinical outcomes in patients … the use of convalescent plasma
in patients with Covid-19 in … -analysis only apply to patients hospitalized with moderate or …

… Moreover, several studies showed a shorter hospital stay and lower mortality in patients
treated with convalescent plasma than those who were not treated with convalescent plasma.In …

… mL convalescent plasma with a neutralization titer above 1,000 was transfused in Shen et
al.’s study (6). Patients in … the dosage of convalescent plasma and treat more patients. Finally, …

… from individuals recovered from COVID-19 (COVID-19 convalescent plasma, CCP) was …
hospital of Mantua, Lombardy region, on the compassionate use of CCP in patients hospitalized …